Features of diagnosis and treatment of newly diagnosed atrial fibrillation
https://doi.org/10.30629/0023-2149-2023-101-11-549-555
Abstract
Due to the wide spread in the population and high risk of complications, atrial fibrillation is an important nosology, and doctors of both outpatient and hospital departments should be prepared for its early detection and diagnosis. The absence of specific symptoms and clear causes of onset, as well as the many associated clinical conditions, mean that knowledge of atrial fibrillation, especially its debut — the first diagnosed atrial fibrillation — is particularly necessary for general practitioners. This article analyzes literature on first diagnosed atrial fibrillation, focusing on the peculiarities of the disease’s course, diagnosis, choice of tactics, and treatment. The article introduces readers to information from modern publicly available publications on this topic, providing an overview of the key stages in the historical development of medicine in this area. Based on literary sources, existing problems of underestimating the danger of the disease, lack of unified approaches to patient management, and key definitions and concepts are revealed today.
About the Authors
S. O. Lependin
Central Military Clinical Hospital named after P.V. Mandrykа of the Ministry of Defense
Russian Federation
Russian Federation
Lependin Sergey O.
107014, Moscow
M. B. Patsenko
Branch Military Medical Academy named after S.M. Kirov in Moscow of the Ministry of Defense
Russian Federation
Russian Federation
Patsenko Mikhail B.
107392, Moscow
S. E. Surigina
Branch Military Medical Academy named after S.M. Kirov in Moscow of the Ministry of Defense
Russian Federation
Russian Federation
Surigina Svetlana E.
107392, Moscow
N. V. Morozova
Central Military Clinical Hospital named after P.V. Mandrykа of the Ministry of Defense
Russian Federation
Russian Federation
Morozova Natalia V.
107014, Moscow
V. I. Steklov
Central Military Clinical Hospital named after P.V. Mandrykа of the Ministry of Defense
Russian Federation
Russian Federation
Steklov Vladimir I.
107014, Moscow
References
1. Bokeria L.A., Revishvili A.Sh., Oganov R.G. et. al. Clinical guidelines on diagnostics and treatment of patients with atrial fi brillation. Journal of Arrhythmology. 2010;59(59):53–77. (In Russian).
2. Go A.S., Hylek E.M., Phillips K.A. et. al. Prevalence of diagnosed atrial fi brillation in adults national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fi brillation (ATRIA) study. JAMA. 2001;285(18):2370–2375.
3. Cheung J.W., Keating R.J., Stein K.M. et al. Newly detected atrial fi brillation following dual chamber pacemaker implantation. Journal of Cardiovascular Electrophysiology. 2006;17(12):1323–1328. DOI: 10.1111/j.1540-8167.2006.00648.x
4. Kiliszek M., Ponikowski P., Opolski G. Cardioversion diff erences among fi rst detected episode, paroxysmal, and persistent atrial fi brillation patients in the RHYTHM AF registry in Poland. Cardiology Journal. 2015;22(4):453–458. DOI: 10.5603/CJ.a2015.0006
5. Bunch T.J., Day J.D., Olshansky B. et al. Newly detected atrial fi brillation in patients with an implantable cardioverter-defi brillator is a strong risk marker of increased mortality. Heart Rhythm. 2009;6(1):2–8. DOI: 10.1016/j.hrthm.2008.09.025
6. Bova A.A. Atrial fi brillation in therapeutic practice. Voennaya medicina. 2018;1:6–10. (In Russian).
7. Bаgry А.E., Prikolota O.A., Kotova K.A., Vashakidze N.O., Derevyanko N.Ya., Gritskevich O.S., Bаgry O.N. Rate and rhythm control treatment strategies of new lydiagnosed atrial fi brillation. Crimean journal of internal diseases. 2021;2:25–33. (In Russian).
8. Nieuwlaat R., Capucci A., Camm A.J. et al. Atrial fi brillation management: a prospective survey in ESC member countries the euro heart survey on atrial fi brillation. Eur. Heart J. 2005;26:2422– 2434. DOI:10.1093/eurheartj/ehi505
9. Hammond-Haley M., Providência R., Lambiase P.D. Temporal pattern/episode duration-based classifi cation of atrial fi brillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management? Europace. 2018;20(FI3):f288–f298. DOI: 10.1093/europace/eux178
10. McIntyre W.F., Um K.J., Cheung Ch.C. et al. Atrial fi brillation detected initially during acute medical illness: A systematic review. European Heart Journal: Acute Cardiovascular Care. 2019;8(2):130–141. DOI: 10.1177/2048872618799748
11. Reiff el J.A., Verma A., Kowey P.R. Incidence of previously undiagnosed atrial fi brillation using insertable cardiac monitors in a high-risk population the REVEAL AF study. JAMA. Cardiology Published online. 2017;2(10):1120 –1127. DOI:10.1001/jamacardio.2017.3180
12. Garnvik L.E., Malmo V., Janszky I. Physical activity modifi es the risk of atrial fi brillation in obese individuals: The HUNT3 study. European Journal of PreventiveCardiology. 2018;25(15):1646– 1652. DOI: 10.1177/2047487318784365
13. Romanov A., Martinek M., Purerfellner H. et al. Incidence of atrial fi brillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. Europace. 2018;20(2):263–270. DOI: 10.1093/europace/euw344
14. Mazza A., GraziaBendini M., De Cristofaro R. et al. Pacemakerdetected severe sleep apnea predicts new-onset atrial fi brillation. Europace. 2017;19(12):1937–1943. DOI: 10.1093/europace/euw371
15. Freedman B. et al. Screening for atrial fi brillation. A report of the af-screen international collaboration. Circulation. 2017;135:1851– 1867. DOI: 10.1161/CIRCULATION AHA.116.026693
16. Kikillus N., Hammer G., Wieland S. et al. Algorithm for identifying patients with paroxysmal atrial fi brillation without appearance on the ECG. Proceedings of the 29th Annual International Conference of the IEEE EMBS. 2007.2007;2007:275–278. DOI: 10.1109/IEMBS.2007.4352277
17. Bassand J.-P., Accetta G., Camm A.J. et al. Two-year outcomes of patients with newly diagnosed atrial fi brillation: results from GARFIELD-AF. European Heart Journal. 2016;37(38):2882–2889. DOI: 10.1093/eurheartj/ehw233
18. Bulanova N.A. Atrial fi brillation registered for the fi rst time: characteristics of clinical course, treatment, prognosis. Article in Kardiologiia. 2013;53(2):25–29.
19. Levy S., Maarek M., Coumel Ph. et al. Characterization of diff erent subsets of atrial fi brillation in general practice in France the ALFA study. Circulation. 1999;99:3028–3035. DOI: 10.1161/01.CIR.99.23.3028
20. Shlyakhto E.V., Villevalde S.V., Ezhov A.V., Zenin S.A. et al. Clinical performance of the atrial fi brillation in the Russian. fi ndings from the GLORIA-AF. Russian Journal of Cardiology. 2017;9:149. (In Russian.).
21. Boriani G., Glotzer T.V., Ziegler P.D. et al. Detection of new atrial fi brillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fi brillation burden. Heart Rhythm. 2017;15(3):376–383. DOI: an10.1016/j.hrthm.2017.11.007
22. Snow V., Welss K.B., LeFevre M. et al. Management of newly detected atrial fi brillation:a clinical practice guideline from the American academy of family physicians and the american college of physicians. Annaly aritmologii. 2005;2:5–16. (In Russian)].
23. Pluymaekers H.A., Dudink M. P., Weijs B. et al. Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fi brillation. Neth. Heart J. 2021;29:255–261. DOI: 10.1007/s12471-020-01528-5
24. Cosio F.G., Aliot E., Botto G.L. Delayed rhythm control of atrial fi brillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the fi rst detected episode. Europace. 2008;10:21–27. DOI:10.1093/europace/eum276
25. Kirchhof P., Camm A.J., Goette A. et al. Early rhythm-control therapy in patients with atrial fi brillation. N. Engl. J. Мed. 2020;383(14):1305–1316. DOI: 10.1056/NEJMoa2019422
26. Steklov V.I., Pashchenko M.B., Demyanenko A.V. et al. Diagnostic criteria and treatment of tachyinduced cardiomyopathy: clinical observation. Bulletin of Arrhythmology. 2022;29(4):53–60. (In Russian). DOI: 10.35336/VA-2022-4-08
27. Pope M. K., Hall T.S., Schirripa V. et al. Cardioversion in patients with newly diagnosed non-valvular atrial fi brillation: observational study using prospectively collected registry data. BMJ. 2021;375:e066450. DOI: 10.1136/bmj-2021-066450
28. Hellman T., Kiviniemi T., Vasankari T.et al. Prediction of ineff ective elective cardioversion of atrial fi brillation: a retrospective multicenter patient cohort study. BMC Cardiovascular Disorders. 2017;17:33. DOI:10.1186/s12872-017-0470-0
29. McIntyre W.F., Lengyel A.P., Healeyet J.S. et al. Design and rationale of the atrial fi brillation occurring transiently with stress (AFOTS) incidence study. Journal of Electrocardiology. 2019;57:95–99. DOI: 10.1016/j.jelectrocard.2019.09.014
30. Philippsen T.J., Christensen L.S., Hansen M.G. et al. Detection of subclinical atrial fi brillation in high-risk patients using insertable cardiac monitor. JACC: Clinical electrophysiology. 2017;3(13):1557– 1564. DOI: 10.1016/j.jacep.2017.06.020
Review
For citations:
Lependin S.O., Patsenko M.B., Surigina S.E., Morozova N.V., Steklov V.I. Features of diagnosis and treatment of newly diagnosed atrial fibrillation. Clinical Medicine (Russian Journal). 2023;101(11):549-555. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-11-549-555
Views:
583
Email this article 